Laboratory Billing Companies and False Claims: When the Submitter Knows the Order Is Missing

Laboratory billing company false claims can arise when a submitter knowingly bills for unordered or unperformed tests, or adds diagnoses unsupported by the ordering office’s information. For someone inside the billing operation, the decisive event may be an instruction to add a code, an altered requisition or a claim sent after the missing order was raised. The question is what reached your company, who changed it and what went to the payer. When Medicare pays for tests never performed, taxpayers lose money meant for patient care.

What a Laboratory Billing Company Actually Touches

Under Medicare’s diagnostic testing rules, the doctor’s chart must show why the test was needed. The entity submitting the claim must keep what the ordering office sent and show that the claim matches it.

For an outside healthcare billing company, what matters is what it actually did: the information it received, the edits it made, the claims it submitted and the decisions it referred back to the laboratory. We examine who controlled each of those steps. A service agreement, an instruction from the customer and the biller’s response can answer different parts of that question.

The clinical reason for testing begins with the treating office. The billing operation carries that information into a request for government money.

VitalAxis Changed the Physician on the Claim

VitalAxis, a Maryland billing company, agreed to pay $300,479 in a June 2023 civil settlement over respiratory panels billed for seniors receiving COVID-19 tests. The Justice Department alleged that its laboratory customer directed it to bill tests under a physician who had not ordered them and was ineligible to treat Medicare beneficiaries. VitalAxis obtained another physician’s credentials and billed under that name without authorization. Medicare paid the laboratory.

The billing company’s own substitution is the point. The problem reached the biller, and its response changed the physician identified on the claim. The announcement described allegations resolved by settlement, with no determination of liability.

AIMA’s Billing for Selecta Laboratory

The government’s June 2025 civil complaint announcement alleged that AIMA Business and Medical Support billed Medicare for unnecessary genetic tests on behalf of Excellent Laboratories, doing business as Selecta Laboratory. AIMA supplied billing advice as well as claim submissions. The government alleged that it knew or should have known the tests were unnecessary and had not been ordered by the beneficiaries’ treating physicians.

The announcement describes allegations, with no determination of liability. It places the vendor’s knowledge and submissions at the center of the case; the laboratory received Medicare payments and paid AIMA for its services.

When the Order Is Missing

When an order is missing from the laboratory’s file, we look at the requisition alongside the treating office’s chart. The question is whether the clinician requested the test that reached billing.

The next question is who selected the tests. A standing order can keep producing work long after the original selection. In Model Plan Helps Laboratories Fight Fraud, published in Laboratory Medicine in 1997, a review of the Inspector General’s model plan described monitoring standing orders for continuing validity and having physicians acknowledge customized profiles. A form that generates repeat testing needs a history of the physician’s choices.

Genotox Laboratories admitted in its civil settlement that it offered custom profiles allowing health care providers to preselect tests for all or nearly all their patients, generally in the highest reimbursement categories. The company then performed and billed those tests. The form turned a selection into repeat business.

For a billing employee, that makes the source of the selection important. We look at whether the request came from the treating office, a provider’s saved profile or a later change inside the laboratory, and what information accompanied it.

When the Bill Doesn’t Match the Order

The requested test, the work actually performed and the service billed must line up. Comparing them exposes different decisions: adding a test to an order, charging for work never done, or changing the billing treatment of work that was done.

A Test Added Before the Physician Saw the Result

A whistleblower’s complaint alleged that Berkeley HeartLab added Plavix testing to follow-up panels for patients with high cholesterol, even though the practice’s physicians had discussed using the test for individual patients as needed. The complaint placed the change on the forms reaching billing staff:

In that account, the doctor learned what had been ordered by receiving the result. An employee who knows how the form reached billing can help explain who selected the added service and who understood that the physician had not selected it.

For reflex testing, the question is whether the first result met the doctor’s condition for the additional test. We compare that result with the order and the follow-up charge.

Unbundling changes the bill itself. A panel’s component tests can become separate charges even though the laboratory performed the work as a group. For the billing employee, the useful evidence is the instruction or system setting that produced those separate charges.

The Outside Laboratory Charged Once

A complaint against Laboratory Corporation of America alleged that LabCorp charged Walter Reed for each specimen in a genetic test even though GeneDx charged for the child’s or fetus’s report. The whistleblower quoted an internal email:

LabCorp agreed to pay $2.1 million in March 2023 to settle allegations of overbilling Department of Defense contracts. The alleged overbilling was the gap between the test LabCorp paid for and the specimen charges it sent to the government. The complaint’s email shows that both sides of the transaction were visible inside the business.

Who Knew What, and When?

The biller’s knowledge becomes concrete when a communication identifies the problem and the next claim shows what happened to it. An ordering-office message, a rejected-order record, a revised requisition and the submitted claim can connect the concern to the person who decided to proceed.

Diagnosis edits deserve particular attention. The Inspector General’s laboratory guidance addresses software that inserts diagnosis codes without diagnostic information from the ordering physician, as well as invented information used for claim submission. The source of the diagnosis is the critical connection.

The GlycoMark complaint describes a different route around a payment restriction. The whistleblower alleged that company management encouraged customers to keep billing a noncovered test under a code shared with covered tests, believing Medicare could not distinguish them. The complaint also alleged that management directed the omission of a reimbursement disclaimer. The useful evidence was the instruction about what to tell customers and what to leave out.

If a claim changes after a rejection, we examine the before-and-after versions with you: what changed, where the replacement information came from and who authorized it. If an ordering office canceled testing, its message and the subsequent billing history would address whether that instruction reached the people sending claims. Those are questions about the biller’s own decisions.

What the Centers for Medicare & Medicaid Services Can See in the Claims

The Centers for Medicare & Medicaid Services compares combinations of testing, results, billing, documentation and provider relationships to identify suspicious claims. In its August 2026 laboratory enforcement announcement, the agency reported stopping more than $1.6 billion in potentially improper Medicare laboratory payments since the start of the administration.

The agency described a Texas laboratory suspected of billing for services never performed that changed its billing practices after the agency denied claims, in an attempt to get around its controls. That is the pattern visible to the payer. An insider may be able to explain who directed the change and what the billing staff were told.

What a Billing Employee Can Show

The evidence depends on what your company received, changed and submitted, and what the people making those decisions knew. We work through those connections with you.

Billing knowledge can reach across the transaction. You may understand why a claim was rejected, why its codes changed and why it went back to the payer.

We work with billing employees, managers and laboratory insiders to connect that firsthand knowledge to the underlying records. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

When You Know Why the Claim Went Through

If you know who changed a laboratory order or kept a claim moving after the problem was raised, speak with our whistleblower experts about what happened inside the billing operation. We build your strongest case around those decisions and bring in laboratory fraud whistleblower lawyers who understand billing systems, government payment and referral arrangements. We stay beside you from that first account through the case.